LGR4 and colorectal carcinoma: Further studies on the functions and signaling mechanisms of the LGR4 and Rspo proteins will facilitate the development of therapeutic strategy for human diseases, such as IBD, CRC, and diabetes, by targeting Rspo-LGR4 (Table 1).